A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase

I. Resche, Dana E. Wilkins, Manfréd M. Fischer(Vitos Orthopedic Clinic Kassel), A Pecking(Hôpital René Huguenin), A. A. Fauser, Peter J. Ell(University College Hospital), J.F. Chatal, S. Houston, Gillian Duchesne(University College Hospital), R.D. Rubens(Committee on Publication Ethics), I. Fogelman(Guy's Hospital)
European Journal of Cancer
September 1, 1997
10.1016/s0959-8049(97)00155-x
Cited by 254

Related Papers

Assessment of response to therapy in advanced breast cancer
|British Journal of Cancer|1977|706
Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland
|Cancer|1977|627
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
|Journal of Clinical Oncology|1998|563
Testosterone Secretion and Metabolism in Male Senescence
|The Journal of Clinical Endocrinology & Metabolism|1972|537
Sexual and Physical Health After Sex Reassignment Surgery
|Archives of Sexual Behavior|2005|369